Maram H Zahra
Overview
Explore the profile of Maram H Zahra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Afify S, Hassan G, Zahra M, Nawara H, Abu Quora H, Osman A, et al.
Biomaterials
. 2023 Jul;
301:122249.
PMID: 37506511
The heterogeneous cell population in the stromal microenvironment is considered to be attributed to the multiple sources from which the cells originate. Tumor associated myoepithelial cells (TAMEs) are one of...
2.
Hassan G, Afify S, Zahra M, Nawara H, Kumon K, Iwasaki Y, et al.
Cytotechnology
. 2023 May;
75(3):243-253.
PMID: 37181678
Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-023-00575-1.
3.
Zahra M, Nawara H, Hassan G, Afify S, Seno A, Seno M
Adv Exp Med Biol
. 2023 Jan;
1393:125-139.
PMID: 36587305
Many tumors are resistant to conventional cancer therapies because a tumor is composed of heterogeneous cell population. Especially, subpopulation of cancer stem cells, which have self-renewal and differentiation properties and...
4.
Afify S, Hassan G, Ishii H, Monzur S, Nawara H, Osman A, et al.
Adv Exp Med Biol
. 2023 Jan;
1393:83-101.
PMID: 36587303
Cancer stem cells (CSCs) are small subpopulation sharing similar properties like normal stem such as self-renewal and differentiation potential to direct tumor growth. Last few years, scientists considered CSCs as...
5.
Minematsu H, Afify S, Sugihara Y, Hassan G, Zahra M, Seno A, et al.
Sci Rep
. 2022 Sep;
12(1):15628.
PMID: 36115905
Previously, our group has demonstrated establishment of Cancer Stem Cell (CSC) models from stem cells in the presence of conditioned medium of cancer cell lines. In this study, we tried...
6.
Afify S, Hassan G, Nawara H, Zahra M, Xu Y, Alam M, et al.
J Cell Biochem
. 2022 May;
123(7):1183-1196.
PMID: 35578735
Human Cripto-1 is a member of the epidermal growth factor (EGF)-Cripto-FRL-1-Cryptic (CFC) family family and performs critical roles in cancer and various pathological and developmental processes. Recently we demonstrated that...
7.
Monzur S, Hassan G, Afify S, Kumon K, Mansour H, Nawara H, et al.
Cell Biochem Funct
. 2022 Mar;
40(3):310-320.
PMID: 35285948
Diphenyleneiodonium (DPI) has long been evaluated as an anticancer drug inhibiting NADPH oxidase, the IC in several cancer cell lines was reported 10 µM, which is too high for efficacy....
8.
Hassan G, Zahra M, Seno A, Seno M
Sci Rep
. 2022 Feb;
12(1):2711.
PMID: 35177646
Cancer stem cells (CSCs) are suggested to be responsible for drug resistance and aggressive phenotypes of tumors. Mechanisms of CSC induction are still under investigation. Our lab has established a...
9.
Hassan G, Ohara T, Afify S, Kumon K, Zahra M, Fu X, et al.
J Exp Clin Cancer Res
. 2022 Jan;
41(1):29.
PMID: 35063003
Background: Cancer stem cells (CSCs) are generated under irregular microenvironment in vivo, of which mimic is quite difficult due to the lack of enough information of the factors responsible for...
10.
Kumon K, Afify S, Hassan G, Ueno S, Monzur S, Nawara H, et al.
Sci Rep
. 2021 Dec;
11(1):23977.
PMID: 34907219
Cancer stem cells (CSCs) are subpopulations in the malignant tumors that show self-renewal and multilineage differentiation into tumor microenvironment components that drive tumor growth and heterogeneity. In previous studies, our...